The Role of FSH in Prostate Cancer: A Case Report

Castrate Resistant Prostate Cancer (CRPC) is a difficult entity to treat in the spectrum of prostate cancer disease. Recently, Follicle Stimulating Hormone (FSH) has been shown to play an important part in the natural history of prostate cancer disease progression (Crawford et al., 2014). Here, we d...

Descripción completa

Detalles Bibliográficos
Autores principales: Catarinicchia, Salvatore, Crawford, E. David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909606/
https://www.ncbi.nlm.nih.gov/pubmed/27335783
http://dx.doi.org/10.1016/j.eucr.2016.03.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909606/
https://www.ncbi.nlm.nih.gov/pubmed/27335783
http://dx.doi.org/10.1016/j.eucr.2016.03.011

Ejemplares similares